Return
PepSeA: Peptide Sequence Alignment and Visualization Tools to Enable Lead Optimization
DOI:10.1021/acs.jcim.1c01360.png)
Abstract
En 中文
Therapeutic peptides offer potential advantages over small molecules in terms of selectivity, affinity, and their ability to target undruggable proteins that are associated with a wide range of pathologies. Despite their importance, current molecular design capabilities that inform medicinal chemistry decisions on peptide programs are limited. More specifically, there are unmet needs for structure-activity relationship (SAR) analysis and visualization of linear, cyclic, and cross-linked peptides containing non natural motifs, which are widely used in drug discovery. To bridge this gap, we developed PepSeA (Peptide Sequence Alignment and Visualization), an open-source, freely available package of sequence-based tools (https://github.com/Merck/PepSeA). PepSeA enables multiple sequence alignment of non-natural amino acids and enhanced visualization with the hierarchical editing language for macromolecules (HELM). Via stepwise SAR analysis of a ChEMBL peptide data set, we demonstrate the utility of PepSeA to accelerate decision making in lead optimization campaigns in pharmaceutical setting. PepSeA represents an initial attempt to expand cheminformatics capabilities for therapeutic peptides and to enable rapid and more efficient design-make-test cycles.
Keywords:
CYCLIC-PEPTIDES
DRUG DISCOVERY
N-METHYLATION
IN-VITRO
PROTEIN
MAFFT
THERAPY
THERAPEUTICS
PARALLELIZATION
PERMEABILITY
Journal
IF:
5.3
Papers:
9.1K
Citations:
4.0W
Organization
Cited Papers
Interfering peptides targeting protein-protein interactions: the next generation of drugs?
DRUG DISCOVERY TODAY
IF7.5
In vitro virus: Bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro
FEBS LETTERS
IF3

